Assisted Reproduction in Spain, Outcome and Socioeconomic Determinants of Access
Ido Alon, Jaime Pinilla Dominguez
published 06 Jul, 2021
Read the published version in International Journal for Equity in Health →
Research Question: We analyzed two questions. First, the effectiveness of public Assisted Reproductive Technologies (ART) in Spain compared with private ones, measured by the time since initiating ART treatment until achieving pregnancy, accounting for age and socioeconomic factors. Second, socioeconomic determinants of access to ART, referring primarily to financial means derived by employment, income, and wealth.
Design: We applied statistical models on data extracted from the national Spanish Fertility Survey from 2018. The first topic was analyzed by competing risk survival analysis conducted on a sample of 667 women who initiate ART treatment since 2000. The second, by a Bivariate Probit model conducted on a sample of 672 women older than 41 years who required ART services.
Results: The first analysis raised that throughout the treatment, patients treated exclusively in private clinics had on average a higher cumulative incidence of becoming pregnant compared with patients who approached public clinics. The second analysis raised that both higher household equivalent income and higher education increase the likelihood of accessing ART in a private clinic and decrease the tendency of accessing public clinics or failing to access any service. Moreover, being single decreases the likelihood of accessing public clinics or ART services in general.
Conclusions: Long waiting periods could be the main reason for the lower incidence of getting pregnant in public healthcare, explaining why patients choose private over public care. We develop a broader discussion over the extent of Spanish public funding of ART, the unequal medical outcome, and potential options for optimization.
Assisted Reproductive Technology
Bivariate Probit
Competing Risk Survival Analysis
Public Coverage
Socioeconomic determinants
In Spain, patients treated exclusively in private clinics had on average a higher cumulative incidence of becoming pregnant compared with patients who approached public clinics.
Higher income and higher education increase the likelihood of accessing ART in a private clinic and decrease the likelihood of accessing public clinics or failing to access any service.
Considering long waiting lists and limited resources in public healthcare, policymakers should analyze resource allocation optimization in ART, focusing on public clinics' efficacy by reconsidering both the age limit and the number of cycles.
Since 2008, the volume of Assisted Reproductive Technologies (ART) in Spain has increased by nearly 50%, reaching 149,337 In-Vitro Fertilization (IVF) and 34,100 Intrauterine Insemination (IUI) cycles in 2018 [‎52, ‎54]. Spain is the largest European ART provider and fourth globally. [‎‎7, 14, ‎21, ‎33].
Given that 10–15% of the entire population may suffer from infertility [‎1, ‎5], the rise in ART practices can be explained by several factors. ART is becoming more available, affordable, and endurable while providing better outcomes. Additionally, parenthood postponement increases age-related infertility and upsurges demand [‎3].
In recent years, Spain enjoyed a sharp increase in the number and quality of ART clinics [‎52, ‎54], of which some have become world-leading ART corporations. Nevertheless, Spain has the OECD's second-highest average maternal age at childbirth [32.1 years in 2017) [‎44], and 1.3 children per woman, among the lowest in the world. For a few decades, it has been facing elevated unemployment rates among youngsters and gender-gaps concerning employment, salary, and work contracts. Spaniards are among the oldest in Europe to leave parents' home [‎38, ‎44]. These conditions have ongoingly contributed to marriage1 and pregnancy delay [‎2, ‎11, ‎18, ‎38]. Spain has the highest proportion in Europe of first births to mothers aged 40 or above (8.8% of total births in 2017) [‎22]. In 2018, patients older than 40 years received more than 30% of ART cycles, while 57% of these included egg donations. Spain produces more than half the continent's egg donations [‎21, 54].
Regulations and public provision largely determine whether the demand for ART is being met [‎16, ‎47]. The Spanish law 14/20062 on ART is among the most liberals in Europe. It enables practices with no defined age limit and regulates fertility preservation [‎4‎, 12]. A liberal approach towards gamete donations and PGT, and an abundant supply of specialized clinics make Spain one of the world's most popular destinations for cross-border reproductive care, accounting for about 11% of the country's ART cycles [‎‎51, 54].
ART is an expensive and repetitive treatment with uncertain costs and outcomes. In 2018, average success rates in Spain were 8–27% for a regular cycle, depends on patient's age, and around 37% for donor-eggs cycles [‎54]. Costs in private clinics were 700-1,000 Euro for an IUI cycle, 3,500-5,500 Euro for an IVF cycle, up to 9,000 Euros for an egg donation, and up to 10,000 Euro for PGT [‎28].
Cost reduction of ART through public funding is often justified by the demographic implications of infertility and its strong impact on the quality of life, not only from a social perspective but also as a source for depression, anxiety and conflict in relationships [‎19, ‎‎32, 41, 46]. Fauser et al. [‎23] identified positive attitudes among western European respondents towards some extent of public ART coverage for primary infertility. Additionally, Vida [58, p. 1] argued that "infertility qualifies as an unpredictable incident against which rational agents would choose to insure under ideal conditions and that ART is thereby a matter of collective responsibility". Chambers et al. [‎15] found a positive association between affordability and utilization. Nevertheless, public coverage is important not only to provide equal access but also to reduce the financial burden on young parents [‎16]. It also serves to moderate the principal-agent problem, in which physicians may potentially lead to commodification and supplier-induced demand by offering unnecessary treatments and add-ons [‎‎4, ‎17,‎27, 45].
Spanish national health system covers up to three ART cycles for childless couples, up to 40 years for women and 55 for men [‎4]. However, patients spend around one year on average on waiting lists for public clinics [‎‎25, 40], which may delay the potential solution, harm treatment outcomes [‎13], and produce distrust. In practice, about 75% of cycles are elaborated by private clinics, which are also responsible for nearly all donor eggs3 and PGT (therefore for the majority of reproductive tourism) [‎42, 49, ‎54]. Some private insurance policies cover a limited number of cycles, usually one or two, with few exceptions. Coverage for donor gametes and PGT is limited.
This study examines two topics. First, the effectiveness of public ART services in Spain compared with private services, measured by the time since initiating treatment until achieving pregnancy, accounting for age and some socioeconomic factors. Second, the socio economic determinants of access to ART, referring primarily to financial means derived by employment, income, and wealth. Additionally, education levels are usually associated with both the postponement of childbearing and a larger tendency to seek medical help. Lower socioeconomic background (and education) may be associated with higher infertility levels, while a higher socioeconomic background may be associated with higher tendency to seek medical solutions [‎9, ‎19, 20].
This study supplements previous research about diverse public ART policies concerning the balance between public and private care, socioeconomic disparities, and differences in outcome [‎12, 13, ‎55]. We applied two statistical models on data extracted from the national Spanish Fertility Survey (SFS), conducted in 2018 by the National Statistics Institute (INE). First, competing risk survival analysis with 'stopping the treatment' as the competing event. Second, a Bivariate Probit (Biprobit) model to identify how socioeconomic determinants affect access to services in public and private clinics.
The first model suggested that patients treated exclusively in private clinics had a higher cumulative incidence of becoming pregnant, on average and throughout the treatment, compared with patients who approached public clinics. The second showed evidence for inequality in access based on income, education levels, and marital status. Additionally, it shows that many patients choose private over public. Finally, we developed a broader discussion over the extent of public funding of ART, long waiting periods for public care, unequal medical outcome, and optimization.
1We refer here to marriage or domestic partnership.
2Partially revised by Law 19/2015
3Public clinics provide donor eggs only in exceptional cases of genetic disorders, or early ovarian failure before the age of 35
Our data source is the SFS [‎31], which addressed participants aged 18 to 55 who reside in family households throughout the Spanish national territory. It was conducted to identify the determining factors of recent, current, and expected fertility, i.e., factors influencing whether or not (and when) to have children. The SFS was household-based with stratified two-stage sampling and included 17,175 participants (14,556 women and 2,619 men)4.
2.1. Variable definition
Two questions are elaborated in this study: 1) Do public ART services in Spain provide an effective solution compared to private services? 2) How socioeconomic determinants affect ART utilization in public and private clinics? Our sample comprises 1) women who reported to undergo ART (including IUI) since 2000 or are currently undergoing treatment. 2) Women aged 41 years or more who required ART services.
For both samples, timed intercourse and surrogate gestation have not been considered. In the first, access to ART should have been carried out in the year 2000 or later to avoid the bias of available technology. Concerning the second, women younger than 41 were not included since they may still access public coverage in the future, which may bias our results. To enable our analysis of socioeconomic determinants, some respondents were excluded. Such are those whose reasons not to access ART were: 'preference for adoption or surrogacy', 'physical and health impediments', 'religious impediments' and 'unwillingness by the partner', since it is unclear what stands behind their unwillingness (e.g., financial, religion or any other reasons). Conversely, we included the reasons 'Financial barriers' (83 respondents), 'lack of coverage by social security' (35), 'lack of time' (17), and 'fear of stress or emotional burden' (33). These reasons may very well be associated with socioeconomics determinants since a favorable financial situation may "buy" time and reduce stress, although demanding professional career produces "lack of time".
inclusion and exclusion criteria for each study question
Question 1: Do public ART clinics in Spain provide an effective solution compared to private ART clinics?
Question 2: How socioeconomic determinants affect ART utilization in public and private clinics in Spain?
Women who initiate ART treatment since 2000.
N = 690
Women aged 41 or older who tried to get pregnant.
N = 5,897
Type of ART timed intercourse (22) or surrogate gestation (1).
N = 23
Exclusion criteria (Reasons for non-access to ART):
Non-requirement (5,110), physical and health impediments (59), preference for adoption or surrogacy (13), religious impediments (10) and unwillingness by the partner (22), timed intercourse was applied (11).
Final Sample size = 667
Our analysis focused on several outcomes related to access to ART. The socioeconomics determinants of access to treatment included in our regression models are marital status5, education level, equivalent monthly household6 and personal income in euros, and geographic location (autonomous community).
Our two study questions were answered using the following statistical approaches: First, competing risk survival analysis with 'stopping the treatment' as the competing event. This model serves to identify factors associated with the success of ART. Second, a Bivariate Probit (Biprobit) model to study how socioeconomic determinants affect ART utilization in public and private clinics.
The datasets included sample weights to account for sample balancing. The standard errors associated with specific estimates, p-values and confidence intervals are adjusted for the design effects.
2.3. Competing risk regression
Cross-sectional SFS data in 2018 were used as baseline time-points for a monthly backward tracing of outcomes related to ART based on respondents' answers about their past and present experiences. The SFS provides data from 667 women who underwent ART in Spain between 2000 and 2018. The data includes the number of treatment duration in months. The end of the treatment was reported as two different competing events: Success, i.e., "I have had a child, or I am pregnant', and 'stopped treatment'. Observations were censored if the person is currently being treated.
We are interested in studying the duration from initiating ART treatment until achieving pregnancy concerning age (at which ART is administered) and socioeconomic factors. Stopping or suspending ART is a competing event: the person undergoing ART may desist (for example, due to health or financial problems), impeding the event of interest.
We use the Fine and Gray model [6, ‎24] based on the idea of the Sub-distribution Hazard Function (SHF), which was specifically developed to analyze the association between covariates and risk estimates in the presence of competing events.
2.4. Bivariate Probit regression
The probabilities of being treated with ART in a private or public clinic can be estimated separately using a discrete choice model. However, these models may yield inconsistencies or bias. Due to the substitution between the two alternative service providers, public and private, the two equations' error terms could be correlated. Therefore, the Bivariate Probit model (Biprobit) is the more appropriate estimator [‎30]. It has been used in health economics research: to study the impact of a personal income tax reform on health insurance demand [‎48, ‎56], assess the probability of hospitalized cardiac patients to experience anxiety or depression [‎26], or examine the influence of public and private coverage on the mortality of HIV patients [‎8].
Not all determinants of access to ART are exogenous. Disentangling the cause-and-effect relationship between income or education levels and access to ART can be complicated. Better economic conditions may improve access to ART services, especially in a private clinic, either by paying out-of-pocket or private health insurance. However, higher valorization of women's time is associated with a higher level of personal and household income, and alternatively, with lower levels of lifetime fertility and therefore greater tendency to require ART services. We address this potential endogeneity by jointly estimating the Biprobit model discussed above, with an additional equation for income and education level. We use parents' (of the respondent) education level as instrumental variables.
The different models were estimated using the conditional mixed process package [‎50]. It employs the Geweke-Hajivassiliou-Kean algorithm, a simulated maximum likelihood procedure, to obtain parameter estimates.
All regression estimations were carried out using the software package Stata 15.1. The descriptive analysis, as well as regression models, were estimated using the SVY survey data module. We controlled for the standard sociodemographic factors and the Autonomous Communities. In our analysis, 10%, 5%, and 1% were used as statistical significance levels.
4https://www.ine.es/en/prensa/ef_2018_d_en.pdf
5The Spanish law: RD 1030/2006 enables access to public coverage of ART to single women (and lesbian couples). However, between 2013 and 2019, the health ministry restricted public ART services exclusively to married couples, despite that in some autonomous communities, singles and lesbian couples were still eligible.
6The Oxford equivalence scale (OECD, 1982) is used to adjust the predicted disposable monthly income for differences in household composition.
7StataCorp. (2017). Stata statistical software: Release 10. College Station, TX: StataCorp LP
As shown in Table 2, in both samples, the share of women who approached ART services in private clinics is considerably larger than the proportion of those who approached public clinics.
Variable definitions and descriptive statistics
Sample for competing risk model: Do public ART services in Spain provide an effective solution compared to private ART services?
Sample for bivariate probit model*: How socioeconomic determinants affect ART utilization in public and private clinics in Spain?
(Linearized standard error)
or %
Stopped ART treatment
Currently under ART treatment
No. of months undergoing ART treatment
Age (years) at onset of ART treatment
34.51 (0.28)**
ART in the private clinic (1 yes; 0 no)
ART in the public clinic (1 yes; 0 no)
ART in both public and private clinics (1 yes; 0 no)
Did not access ART (1 yes; 0 no)
Marital status single (1 yes; 0 no)
Primary education (reference)
High education
Equivalent household monthly income (€)
1,259 (28.85)
1,194.29 (28.08)
Personal monthly income (€)
Population size
Notes: Descriptive statistics are weighted to correct for the complex survey design by the SFS.
*Sample include only women aged from 41 to 55.
** Mean age at onset of ART treatment for 504 respondent who accessed ART.
3.1. Competing risk model
In our sample, 310 women became pregnant, 285 stopped treatment, and 72 were censored (were still ongoing treatment while replying). Moreover, success rates were 52.9% for those treated exclusively in private clinics, compared with 42.4% for public clinics and 40.4% for both public and private.
Table 3 summarizes four competing risk models all based on the respondents' age at treatment and the clinic type. Models 1.2–1.4 incorporate education, equivalent household monthly income, and personal monthly income.
Competing risk models to identify factors associated with success (got pregnant)
Got pregnant (event of interest): 310
Stopping ART treatment (competing event): 285
Lost to follow-up (censored): 72
Model 1.1
(Robust. Std. Err)
Age (years) of access to ART treatment
(0.0148)***
(0.0183)**
ART in the public clinic only (1 yes; 0 no)
(reference)
ART in the private clinic only (1 yes; 0 no)
(0.2107)
(< 0.0001)
Akaike's information criterion (AIC)
Note: *** p < 0.001; ** p < 0.01; * p < 0.05. SHR: estimated sub-hazard ratios. Robust standard errors in parenthesis. Robust standard Error are clustered by Autonomous Communities.
In the first model, the estimated sub-hazard ratio for patients' age at ART onset is lower than 1 (0.961). We may interpret this as evidence that a 1-year increase in age is associated with a 3.9% decrease in the incidence of becoming pregnant for women who are still ongoing treatment. Moreover, the estimated sub-hazard ratio for a private clinic is greater than 1 (1.6675), meaning that receiving ART treatment in private against public clinic is associated with a higher incidence of pregnancy controlling regarding age at accessing ART.
Furthermore, the effects of primary and secondary education (model 1.2), equivalent household income (model 1.3), and personal income (model 1.4) were statistically non-significant. Nevertheless, according to the AIC, the best-fit is model 1.2 (lowest value, AIC = 3638.19), where the sub-distribution hazard of becoming pregnant was 41.36% higher for women with high education than for women with primary education.
In our analysis (Table 3), we found that while accessing ART in a private clinic, there is an increase in the incidence of success at the expense of stopping treatment. To demonstrate it visually, we compare two CIF curves based on model 1.2 results (Fig. 1). One for private clinic = 1 and one for private clinic = 0 (ART in a public clinic or both). For both, we adopt the sample's mean of 34 years as the age at accessing ART and high education level, which counts for 46% of the sample.
Hence, considering high education and 34 years, the cumulative incidence of becoming pregnant within 1, 2,…, and 8 years of treatment is roughly 39%, 55%,…, 72% when ART is conducted in private clinics and roughly 28%, 42%,…, 58% when ART is conducted in public clinics or both types. Both probabilities consider stopping ART as an alternative.
Figure 1 shows that a gap regarding the average cumulative incidences of success is opening during the first years in favor of being treated exclusively in private clinics. This gap is later not narrowing and remains around 0.14 points.
3.2. Bivariate Probit models for private or public clinics
No. of respondents
Mean age at onset
% Singles
Private clinics
59.52% [52.99%-65.73%] (95% IC)
Public clinics
25.76% [19.90%-32.63%]
Both types
Table 5 presents Bivariate Probit models of two outcomes, ART treatment in private and in public clinics. The estimated correlation coefficients ρ12 between the random error terms of ART in a private clinic and public clinic equations are ≈ -0.33, and significant in all models, which denotes a close relationship between the unobserved determinants of the choice of two alternatives.
Household and personal income affect the likelihood of being treated, positively for private clinics and negatively for public ones. Also, a positive association between access to a private clinic and being single is observed. Moreover, with a higher education level, the likelihood of being treated in a private clinic increases and the likelihood of being treated by public clinic decreases.
As we may have expected, parents' education has the strongest association with the respondent's education level (mother more than father), followed by personal and household income. All estimations control for the region of residence (results are not shown for simplification).
Bivariate Probit models: Mixed-process regression
Private sector ART Eq. 1
0.0007 (0.0001)***
0.0005 (0.001)***
-0.139 (0.1540)
-0.103 (0.152)
-0.2196 (0.1564)
Primary education (ref.)
0.3202 (0.2223)
Public sector ART Eq. 2
-0.0003 (0.0001)**
-0.394 (0.166)**
-0.3869 (0.2311)*
-0.7700 (0.254)***
Household income Equation 3
Personal income Eq. 3
Personal education level Eq. 3
Parents' education level
23.79 (124.27)
-10.69 (155.57)
134.04 (126.20)
0.7018 (0.2862)**
313.25 (143.49)**
373.61 (202.39)*
486.24 (198.1)**
424.46 (222.4)*
F-test of overall significance
F(6, 656) Prob > F
< 0.0001
ρ12
-0.3285***
-0.2636*
Note: *** p < 0.001; ** p < 0.01; * p < 0.05. Robust standard errors in parenthesis. Covariates, not shown here, are regional dummies. ρ12 is the correlation between the error terms in Eqs. 1 and 2; ρ13 is the correlation between the error terms in Eqs. 1 and 3; ρ23 is the correlation between the error terms in Eqs. 2 and 3.
To express the more intuitive change in the predicted probability of accessing private or public clinics, we present the Average Marginal Effects (AME) calculated from the fitted models' predictions (Table 6) at different values of the remaining covariates. Table 6 contains the AME for all covariates in each of the models.
An increase of 100 euros in the monthly household equivalent income is associated with an increase of 0.022 in the likelihood to access a private clinic and no significant effect in the likelihood to access a public clinic, as well as with a decrease of 0.012 in the probability of failing to access service8.
Moreover, an increase of 100 euros in personal income is associated with an increase in the likelihood of accessing private clinics (0.019). It also has a significant negative effect of -0.008 on the probabilities of both accessing a public clinic and not accessing any service9.
Compared with primary education (reference variable), the effect of high education on accessing a private clinic is an average increase of 0.484 points on the probability scale, with a 95% confidence interval of [0.342; 0.626]. Alternatively, (high) education has a negative effect on accessing a public clinic. High education decreases the likelihoods of accessing public clinics or have no access, by 0.254 and 0.177, respectively. Finally, being a single woman decreases the likelihood of accessing public care by 0.115 and increases by 0.134 the overall likelihood of having no access to ART.
Average marginal effects (AME) for ART in private or public sector
AME on probability of being treated in a private clinic
dp/dx
[95% CI]
Equivalent household monthly income (measured in hundreds of euros)
0.02199***
[0.0145; 0.0295]
Personal monthly income (measured in hundreds of euros)
[-0.367; 0.2492]
0.2335***
[-0.1746; 0.0289]
AME on probability of being treated in a public clinic
[-0.0111; 0.004]
-0.00778**
[-0.0152; -0.0003]
-0.1453**
AME on probability of having no access to ART
-0.01154***
0.1335**
Note: *** p < 0.01; ** p < 0.05; * p < 0.1. dp/dx show the first derivative of the response variable (in terms of probability) with respect to the covariate, for factor levels is the discrete change from the reference level. Standard errors using in the 95% confidence interval of the effect (95% CI) are obtained by the delta method.
8Concerning the third part of Table 6 (no access to ART), it is important to note that a negative effect on the probability of not accessing ART is interpreted as a positive effect on the probability of accessing ART in general.
9See the previous note.
4. Discussion & Conclusions
The analyses raised a few trends among Spanish ART patients' behavior. First, patients who were treated exclusively in public clinics or who combined treatment in both public and private had, on average and throughout the treatment, a lower cumulative incidence of becoming pregnant compared with patients who were treated exclusively in private clinics (Fig. 1). Second, women with a larger income and higher education levels had a higher likelihood of approaching ART services in private clinics and a lower tendency of approaching public clinics. Third, women of lower socioeconomic backgrounds had a lower likelihood of accessing ART services in general. Additionally, our model quantifies the estimated effect of income on the probability of accessing ART in private or public clinics or having no access. Finally, single women had a lower probability of being treated in public clinics and accessing ART services in general since they were excluded from public services in many autonomous communities [‎36].
Concerning the gap in the cumulative incidence of getting pregnant (model 1.2, Fig. 1). Some patients exercise their right for public coverage first, whereas others begin treatment in a private clinic while remaining on the public clinic's waiting list [‎13‎, 49]. However, public coverage is limited to three cycles and the average waiting time between cycles is around one year. We can conclude that, following 36 months, most patients are treated in private clinics, although the gap remains constant. Based on the National Activity Registry by the Spanish Fertility Society (SEF) and as analyzed by Romero et al. [‎49], we may assume that the quality of care and success rates in public ART clinics in Spain does not fall from the sector's standards [49, ‎53]. It is difficult to determine that private clinics produce a significantly better outcome [‎13], since they may handle better prognosis and treat "good" patients with their own eggs and patients of poor embryonic development or low ovarian reserve with donor eggs.
Hence, we identify three factors that may explain the gap in the cumulative incidence of success. First, long waiting periods in public clinics [‎40, ‎25] prolong the treatment and delay success. Second, a patient older than 35 years with a poor prognosis would more commonly be offered to repeat another cycle, using her own eggs, while private centers offer egg donation earlier. Third, some patients would stop treatment after exhausting their right for three subsidized cycles.
As we may learn from the Biprobit models, Spanish patients are aware of public ART disadvantages and perceive better odds within private clinics. Despite the availability of three publicly covered cycles, 41% of the respondent (55% of the patients) accessed ART exclusively in private clinics. At the onset of treatment, their mean age was 35.5, within the eligible age for public care (we have no information about marital status at treatment onset). The tendency to approach private care is due to long waiting lists and other preferences [13, ‎55]. Only 12% of the respondents combined both types of services. Additionally, 21% accessed only public clinics; of them, 58% did not get pregnant and stopped treatment.
Also, 26% of the respondents required ART but did not access any service. The main barriers are clearly financial, while 21% reported ineligibility for public care, which could be due to advanced age or being single (we do not know their age or status at the time of requiring ART).
Based on these findings, we raise some doubts about the operating principles of public ART services in Spain. The Spanish law 14/2006 on ART is set to provide ART services until 40 years. However, in their current format, public clinics provide an incomplete solution, affected by long waiting lists throughout the treatment, which may interrupt treatments, waste valuable time in their race against aging and could result in reduced outcomes, increased frustration, stress and mistrust [‎13‎,‎ 39, ‎40, ‎49, 57].
This situation incentivizes most patients, particularly those of higher education and income, to seek services exclusively in private clinics. The dependency on the private sector intensifies ART's commodification, results in supplier-induced demand, i.e., private centers often rush patients to acquire costly solutions and offer some excessive add-ons [‎3, ‎4, ‎17, ‎27, ‎45].
Thus, bearing in mind the limited resources and different priorities in public healthcare, we suggest that Spanish policymakers should analyze resource allocation optimization in ART, focusing on public clinics' efficacy by reconsidering both the age limit and the number of cycles. Perhaps, reducing the eligible age may enable faster provision for younger, more disadvantaged patients who suffer from pre-existing rather than age-related infertility and tend to have fewer financial resources [‎19]. It might also enable providing more than three cycles, which may not be sufficient to fulfill ART potential.
More hypothetically, by funding three ART cycles up to 40 years, this policy signals two wrong messages to the public. First, 40 is still a reasonable age to have a first child and second, three ART cycles should be sufficient. ART registries from various countries, including Spain, illustrate that treatment is becoming less effective after 35 years and that often more cycles are required [‎14‎, 54]. Moreover, it has been suggested that public coverage may lead to an increase in average age at first birth and might even negatively affect fertility rates [‎29, ‎37]. Therefore, ART's limitations and risks in advanced maternal age should also be considered, alongside alternatives that may reduce infertility [‎34] to avoid a social trend of parenthood postponement [‎35].
Our study has a few limitations, mainly derived from the available information by the SFS. It enables us to conduct a cross-section analysis since the participants were surveyed only once at a particular moment. More precisely, the SFS provides data about income and marital status at the time of replying and not while attending or requiring services. Conversely, a longitudinal study could provide clearer conclusions. It is reflected mainly by the variation in income and marital status, which may change during a person's life-course, unlike education levels, which mostly maintain constant. Moreover, the SFS does not report about insurance, waiting periods and the number of children. It reports both employment status and urban status, but we assume that household and personal income already reflect those (and insurance). Additionally, autonomous communities may reflect urban status, as well as distance from clinics.
Finally, we recommend several research directions that can contribute to better understanding and policy planning. First, it would be interesting from a public perspective to evaluate public ART provision in Spain by operational analysis to help find a more effective and efficient allocation of the limited resources. Second, a model of (partially) public funding and private provision (such as the "PADI" plan for dental health program for children [‎10]) should be evaluated and considered as an alternative. Fourth, considering that ART in private clinics may be costly, conducting a survey or a series of interviews could raise important insight into young couples' ongoing financial burden. Finally, about the SFS (conducted in 1999 and 2008), conducting a public fertility survey requires a significant public investment and aims to provide potential researchers with valuable data. When the opportunity to conduct a subsequent survey emerges, its designers should elaborate on an open discussion with researchers who may find interest in exploring the collected data. Sharing experiences and common interests may assist in directing the survey towards researchers' needs.
*Ethics approval and consent to participate - Not Applicable
*Consent for publication - Not Applicable
This paper Is based on data extracted from a public survey, there is no need for ethics approval statement or patient consent statement.
*Availability of data and material - https://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736177006&menu=resultados&idp=1254735573002#!tabs-1254736195659
*Competing interests - The authors declare no conflict of interest.
*Funding - This study was funded by project ECO2017-83771-C3-2 under the 'National Program for Research, Development and Innovation to Address the Challenges of Society: National Plan for Scientific Research and Technical Innovation, 2017–2020 funded by the Ministry of Economy and Competitiveness of Spain.
*Authors' contributions - Dr. Jaime Pinilla Domínguez prepared the model and wrote the method section. Dr. Ido Alon assisted in modelling and wrote the rest of the manuscript.
*Acknowledgements - Not Applicable (no participants)
Agarwal, A., Mulgund, A., Hamada, A., & Chyatte, M. R. (2015). A Unique View on Male Infertility Around the Globe. Reproductive Biology and Endocrinology, doi 10.1186/s12958-015-0032-1.
Ahn, N., & Mira, P. (2001). Job Bust, Baby Bust?: Evidence from Spain. Journal of Population Economics, 14: 505-521, doi.org/10.1007/s001480100093.
Alon, I., Guimon, J., & Urbanos-Garrido, R. (2019a). What to expect from assisted reproductive technologies? Experts' forecasts for the next two decades. Technological Forecasting and Social Change, Vol. 148, doi: org/10.1016/j.techfore.2019.119722.
Alon, I., Guimon, J., & Urbanos-Garrido, R. (2019b). Regulatory responses to assisted reproductive technology: a comparative analysis of Spain and Israel. Journal of Assisted Reproduction and Genetics, 36, pages1665–168; https://doi.org/10.1007/s10815-019-01525-7.
ASRM, P. C. (2015). Diagnostic evaluation of the infertile male: a committee opinion. Fertility and Sterility, 103(3), e18-25. doi: 10.1016/j.fertnstert.2014.12.103.
Austin, P. C., & Fine, J. P. (2017). Practical Recommendations for Reporting Fine-Gray Model Analyses for Competing Risk Data. Statistics in Medicine, 36(27):4391-4400;.doi:10.1002/sim.7501.
Bai et al. (2020). Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016. Human Reproduction, Feb 29;35(2):446-452. doi: 10.1093/humrep/dez245.
Bhattacharya, J., Goldman, D., & McCaffrey, D. (2006). Estimating probit models with self-selected treatments. Search Results, 25(3): 389-413, doi: https://doi.org/10.1002/sim.2226.
Bitler, M., & Schmidt, L. (2006). Health disparities and inferitlity: impacts of state-level insurance mandates. Fertil Steril, 85:858–865, https://doi.org/10.1016/j.fertnstert.2005.11.038.
Bravo, M., San Martín, L., Casals, E., Eaton, K. A., & Widström, E. (2015). The healthcare system and the provision of oral healthcare in European Union member states. Part 2: Spain. British Dental Journal, 219, 547 - 551, doi:10.1038/sj.bdj.2015.922.
Bravo-Moreno, A. (2017). Politics, Doctors, Assisted Reproductive Technologies & Religion: Transgenerational Understandings and Experiences of Single Motherhood in Spain. Health Care for Women International, 38:10, 1058-1074, doi: 10.1080/07399332.2017.1360890.
Brigham, K. B., Cadier, B., & Chevreul, K. (2013). The Diversity of Regulation and Public Financing of IVF in Europe and Its Impact on Utilization. Human Reproduction, 3, 666-75. doi: 10.1093/humrep/des418.
Castilla, J., Hernandez, E., Cabello, Y., Navarro, J., Hernandez, J., Gomez, J., . . . Coroleu, B. (2009). Assisted Reproductive Technologies in Public and Private Clinics. Reproductive BioMedicine Online , 19, no. 6. p. 872–78., doi: 10.1016/j.rbmo.2009.09.028.
(2018). Assisted Reproductive Technology - National Summary Report 2016. Atlanta, US,: Centers for Disease Control and Prevention, American Society for Reproductive Medicine, https://www.cdc.gov/art/pdf/2016-report/ART-2016-National-Summary-Report.pdf.
Chambers, G. M. et al.,. (2014). The Impact of Consumer Affordability on Access to Assisted Reproductive Technologies and Embryo Transfer Practices: an International Analysis. Fertility and Sterility, 101(1), 191-198.e4, doi: 10.1016/j.fertnstert.2013.09.005.
Chambers, G. M., Sullivan, E. A., Ishihara, O., Chapman, M. G., & Adamson, G. D. (2009). The Economic Impact of Assisted Reproductive Technology: a Review of Selected Developed Countries. Fertility and Sterility, 91(6), 2281-94, doi: 10.1016/j.fertnstert.2009.04.029.
Cutler, D., Skinner, J. S., L., Stern, A. D., & Wennberg, D. (2019). Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending. American Economic Journal: Economic Policy, 11(1) 192–221, doi: org/10.1257/pol.20150421.
De la Rica, S., & Iza, A. (2005). Career Planning in Spain: Do Fixed-term Contracts Delay Marriage and Parenthood? Review of Economics of the Household, 3, 49–73, DOI: 10.1007/s11150-004-0979-8.
Dhalwani, N., Fiaschi, L., West, J., & Tata, L. (2013). Occurrence of Fertility Problems Presenting to Primary Care: Population-Level Estimates of Clinical Burden and Socioeconomic Inequalities Across the UK. Human Reproduction, Vol.28, No.4 pp. 960–968, doi:10.1093/humrep/des451.
Eisenberg, M. L., Smith, F., Millstein, S. G., Nachtigall, R. D., Adler, N. E., Pasch, L. A., & Katz, P. P. (2010). Infertility Outcomes Program Project Group. Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective U.S. cohort. Fertil Steril, 94:2369–2371, https://dx.doi.org/10.1016%2Fj.fertnstert.2010.03.068.
ESHRE. (2020). Assisted Reproductive Technology in Europe, 2016: Results Generated from European Registers by ESHRE. Human Reproduction, doi:10.1093/hropen/hoaa032.
EUROSTAT. (2019, Aug 1). Retrieved from https://ec.europa.eu/eurostat/en/web/products-eurostat-news/-/DDN-20190801-1
Fauser, B., Boivin, J., Barri PN, T. B., & Levy-Toledano, R. (2019). Beliefs, Attitudes and Funding of Assisted Reproductive Technology: Public Perception of Over 6,000 Respondents from 6 European Countries. PLoS ONE, 14(1), e0211150, doi: org/10.1371/journal.pone.0211150.
Fine, J. P., & Gray, R. J. (1999). Proportional Hazards Model for the Subdistribution of a Competing Risk. Journal of the American Statistical Association, 94:496–509. https://doi.org/10.1080/01621459.1999.10474144.
García de Miguel, L., & Salvador, Z. (2019, 11 08). Reproducción Asistida ORG. Retrieved from Reproducción asistida en la Seguridad Social española: https://www.reproduccionasistida.org/reproduccion-asistida-en-la-seguridad-social-espanola/
Giammanco, M. D., & Gitto, L. (2016). Coping, uncertainty and health-related quality of life as determinants of anxiety and depression on a sample of hospitalized cardiac patients in Southern Italy. Quality of Life Research, 25(11): 2941-2956, doi: 10.1007/s11136-016-1323-5.
Gleicher, N., Kushnir, V., & Barad, D. H. (2019). Worldwide decline of IVF birth rates and its probable causes. Human Reproduction Open, Aug 8;2019(3):hoz017. doi: 10.1093/hropen/hoz017.
González-Viejo, L., Dolz Arroyo, M., Salgado, S., & Salvado, Z. (2019). Precios de los tratamientos de reproducción asistida. https://www.reproduccionasistida.org/precios-de-tratamientos-de-reproduccion-asistida/: Reproduccion Asistida ORG.
Hashiloni-Dolev, Y., Kaplan, A., & Shkedi-Rafid, S. (2011). The Fertility Myth: Israeli Students' Knowledge Regarding Age-Related Fertility Decline and Late Pregnancies in an Era of Assisted Reproduction Technology. Human Reproduction, 11, 3045-53, doi: 10.1093/humrep/der304.
Heckman, J. J. (1978;). Dummy endogenous variables in a simultaneous equation system. Econometrica. Econometrica, 46(4): 931-959, doi: 10.3386/w0177.
INE. (2019, Apr 09). Encuesta de Fecundidad de 2018. Retrieved from Instituto Nacional de Estadística: https://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736177006&menu=resultados&idp=1254735573002
Inhorn, M. C., & Patrizio, P. (2015). Infertility Around the Globe: New Thinking on Gender, Reproductive Technologies and Global Movements in the 21st Century. Human Reproduction Update, 21, 4, 411–426, doi: 10.1093/humupd/dmv016.
Ishihara, O. e. (2019). Assisted reproductive technology in Japan: A summary report for 2017 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol., DOI: 10.1002/rmb2.12307.
Lemoine, M.-E., & Ravitsky, V. (2013). Toward a Public Health Approach to Infertility: The Ethical Dimensions of Infertility Prevention. Public Health Ethics, 1-15, doi:10.1093/phe/pht026.
Lemoine, M.-E., & Ravitsky, V. (2015). Sleepwalking Into Infertility: The Need for a Public Health Approach Toward Advanced Maternal Age. The American Journal of Bioethics, 15:11, 37-48. doi: 10.1080/15265161.2015.1088973.
Lopez-Rodriguez, S. (2017). Public Policies and the Production of Vulnerability Spaces. The Construction of the Woman-Mother in Spanish Political Discourse. Revista Española de Ciencia Política, 44, 97-120.
Machado, M. P., & Galdeano, A. S. (2011). Coverage of Infertility Treatment and Fertility Outcomes: Do Women Catch Up? Bonn, Germany: IZA Discussion, Paperhttp://ftp.iza.org/dp5783.pdf.
Marre, D., San Román, B., & Guerra, D. (2018). On Reproductive Work in Spain: Transnational Adoption, Egg Donation, Surrogacy. Medical Anthropology, 37, 2, 158–173, doi: org/10.1080/01459740.2017.1361947.
Martin-Arroyo, J. (2019, MAY 13). Hasta Tres Años de Espera para Poder Ser Madre. El Pais, p. https://elpais.com/sociedad/2019/05/12/actualidad/1557676986_761783.html.
Medina, M. A., & Mateo, J. J. (2019, Jul 27). La Angustia de Pasar Años Esperando un Tratamiento de Fertilidad en la Sanidad Pública de Madrid. El Pais, p. https://elpais.com/ccaa/2019/07/26/madrid/1564138816_643498.html.
Melhuus, M. (2012). Problems of Conception, Issues of Law, Biotechnologgy, Indviduals and Kinship. berghahn Books.
Navarro Espigares, J. L., Navarro, L. M., Castilla Alcalá, J. A., & Hernández Torres, E. (2006). Coste de las Técnicas de Reproducción Asistida en un Hospital Público. Gaceta Sanitaria, 20, no. 5: 382–90. https://doi.org/10.1157/13093207.
OECD. (1982). The OECD List of Social Indicators. Paris: OECD.
OECD. (2020). OECD - Fertility Rates. Retrieved from http://www.oecd.org/els/family/database.htm
Pavone, V., & Arias, F. (2012). Beyond the Geneticization Thesis: The Political Economy of PGD/PGS in Spain. Science, Technology, & Human Values, 37(3) 235-261, doi: 10.1177/0162243911411195.
Pennings, G. W., Shenfield, F., Cohen, J., Tarlatzis, B., & Devroey, P. (2008). ESHRETask Force on Ethics and Law 14: Equity of Access to Assisted Reproductive Technology. Human Reproduction, 23, 4. p. 772-74, doi:.org/10.1093/humrep/den037.
Präg, P., & Mills, M. C. (2017). Cultural Determinants Influence Assisted Reproduction Usage in Europe More Than Economic and Demographic Factors. Human Reproduction, Vol.32, No.11 pp. 2305–2314, doi:10.1093/humrep/dex298.
Rodríguez, M., & Stoyanova, A. (2008). Changes in the demand for private medical insurance following a shift in tax incentives. Health Economics, 17: 185-202.
Romero, B., Rodriguez-Guirado, S., Casas, A. B., de la Fuente, L., Martin, B., Monzo, A., . . . Castilla, J. A. (2020). Análisis de los indicadores de calidad entre los diferentes centros públicos espa˜noles en técnicas de reproducción asistida; benchmarking. Medicina Reproductiva y Embriología Clínica, 7, 51--59, doi.org/10.1016/j.medre.2019.12.001.
Roodman, D. (2011). Fitting fully observed recursive mixed-process models with CMP. Stata Journal, 11(2): 159-206, doi: 10.1177/1536867X1101100202.
Salama, M., Isachenko, V., Isachenko, E., Rahimi, G., Mallmann, P., Westphal, L. M., . . . Patrizio, P. (2018, July). Cross Border Reproductive Care (CBRC): A Growing Global Phenomenon with Multidimensional Implications (a Systematic and Critical Review). Journal of Assisted Reproduction and Genetics, 35(7), 1277–88. Retrieved from https://doi.org/10.1007/s10815-018-1181-x
SEF. (2010). Registro FIV-ICSI de la Sociedad Española. https://registrosef.files.wordpress.com/2010/05/registrosef_fiv_icsi_2008.pdf: Sociedad Espanola de Fertilidad.
SEF. (2017). Datos Publicos de los Centros. Retrieved from Sociedad Española de Fertilidad: https://www.registrosef.com/index.aspx#Publicos17
SEF. (2018). Registro Nacional de Actividad - Técnicas de Reproducción Asistida , Informe estadístico de Técnicas de Reproducción Asistida 2018. Sociedad Espanola de Fertilidad.
Smith et al. (2011). Socioeconomic Disparities in the Use and Success of Fertility Treatments: Analysis of Data from a Prospective Cohort in the United States. Fertility and Sterility, 96. 1., p.96-101, doi: 10.1016/j.fertnstert.2011.04.054.
Stoyanova, A., & Pinilla, J. (2020). The Evolution of Mental Health in the Context of Transitory Economic Changes. Appl Health Econ Health Policy, Apr;18(2):203-221; doi: 10.1007/s40258-019-00537-9.
Tarabusi, M., Volpe, A., & Facchinetti, E. (2004). Psychological Group Support Attenuates Distress of Waiting in Couples Scheduled for Assisted Reproduction. Journal of Psychosomatic Obstetrics & Gynecology, 25:273–279, doi: 10.1080/01674820400017905.
Vida, P. (2015). Assisted Reproduction and Distributive Justice: Assisted Reproduction and Distributive Justice. Bioethics, 29,2. p. 108-117, doi: 10.1111/bioe.12067.
Appendix.docx
Editorial decision: Major Revision
Review #2 received at journal
Reviewer #2 agreed at journal
Reviews received at journal
Reviewers invited by journal
Editor assigned by journal
Submission checks completed at journal
Editor invited by journal
First submitted to journal